Search

After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease

AFTER A SPEEDY IPO, EQUILLIUM EXPANDS ANTIBODY R&D TO RENAL DISEASE

Equillium, a biotech that's looking to develop an antibody drug for immuno-inflammatory diseases, has added a form of renal disease...

 
 
 
Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps & More

BIO ROUNDUP: AMARIN'S STUNNER, LUNG CANCER NEWS, DATA DUMPS & MORE

Six years ago, a biotech called Amarin won FDA approval of a prescription fish-oil pill, Vascepa, because it could lower triglycerides,...

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug

EQUILLIUM PLANS IPO TO FUND CLINICAL TRIALS FOR TRANSPLANT DRUG

Equillium, a biotech startup developing treatments for immune system disorders-including an immune response that affects some transplant...